cycloleucine has been researched along with Leukemia, T-Cell in 1 studies
Cycloleucine: An amino acid formed by cyclization of leucine. It has cytostatic, immunosuppressive and antineoplastic activities.
1-aminocyclopentanecarboxylic acid : A non-proteinogenic alpha-amino acid that is cyclopentane substituted at position 1 by amino and carboxy groups.
Leukemia, T-Cell: A malignant disease of the T-LYMPHOCYTES in the bone marrow, thymus, and/or blood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jani, TS | 1 |
| Gobejishvili, L | 1 |
| Hote, PT | 1 |
| Barve, AS | 1 |
| Joshi-Barve, S | 1 |
| Kharebava, G | 1 |
| Suttles, J | 1 |
| Chen, T | 1 |
| McClain, CJ | 1 |
| Barve, S | 1 |
1 other study available for cycloleucine and Leukemia, T-Cell
| Article | Year |
|---|---|
Inhibition of methionine adenosyltransferase II induces FasL expression, Fas-DISC formation and caspase-8-dependent apoptotic death in T leukemic cells.
Topics: Apoptosis; BH3 Interacting Domain Death Agonist Protein; CASP8 and FADD-Like Apoptosis Regulating Pr | 2009 |